Latest Breaking News On - Primary biliary cholangitis including pruritus - Page 1 : comparemela.com

The New Drug Application submission is supported by data from a pair of phase 3 studies, a long-term open-label study, and prior phase 2 studies. Cymabay has also requested Priority Review of the NDA.

Klara dickinsonDrug administrationCymabay therapeuticsNew drug applicationPriority reviewBreakthrough therapy designationCymabay submits new drug applicationPrimary biliaryPrimary biliary cholangitis including pruritusPatients without cirrhosisWith compensatedImproves markersCymabay therapeutics announces publicationResults fromPrimary biliary cholangitisFood and drug administration